nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Case of Bing-Neel Syndrome Treated Successfully With Ibrutinib Monotherapy Following Intensive Chemoimmunotherapy
|
Carella, Matteo |
|
|
21 |
11 |
p. e817-e819 |
artikel |
2 |
Accurate Machine-Learning-Based classification of Leukemia from Blood Smear Images
|
Dese, Kokeb |
|
|
21 |
11 |
p. e903-e914 |
artikel |
3 |
A Phase II Study of Venetoclax in Combination With Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma
|
Gasparetto, Cristina |
|
|
21 |
11 |
p. 775-784 |
artikel |
4 |
A Prospective Economic Analysis of Early Outcome Data From the Alliance A041202/ CCTG CLC.2 Randomized Phase III Trial Of Bendamustine-Rituximab Compared With Ibrutinib-Based Regimens in Untreated Older Patients With Chronic Lymphocytic Leukemia
|
Cheung, Matthew C. |
|
|
21 |
11 |
p. 766-774 |
artikel |
5 |
Carfilzomib-Induced Atypical Hemolytic Uremic Syndrome in a Patient With Heterozygous CFHR3/CFHR1 Deletion Treated With Eculizumab
|
Freyer, Craig W. |
|
|
21 |
11 |
p. e845-e849 |
artikel |
6 |
Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas—Retrospective and Multicentric Analysis of Portuguese Centers
|
Rodrigues, Catarina Dantas |
|
|
21 |
11 |
p. e839-e844 |
artikel |
7 |
Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System
|
Apostolidou, Effrosyni |
|
|
21 |
11 |
p. e895-e902 |
artikel |
8 |
Comparative Efficacy of First-Line Treatments of Chronic Lymphocytic Leukemia: Network Meta-Analyses of Survival Curves
|
Alrawashdh, Neda |
|
|
21 |
11 |
p. e820-e831 |
artikel |
9 |
Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Bortezomib, Melphalan, and Prednisone in Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Frailty Subgroup Analysis of ALCYONE
|
Mateos, Maria-Victoria |
|
|
21 |
11 |
p. 785-798 |
artikel |
10 |
Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates
|
Keenan, Madison |
|
|
21 |
11 |
p. 799-804 |
artikel |
11 |
Editorial Board
|
|
|
|
21 |
11 |
p. A5-A6 |
artikel |
12 |
Emerging Targets and Cellular Therapy for Relapsed Refractory Multiple Myeloma: A Systematic Review
|
George, Laeth L. |
|
|
21 |
11 |
p. 741-751 |
artikel |
13 |
Feasibility of Combining the Phosphatidylinositol 3-Kinase Inhibitor Copanlisib With Rituximab-Based Immunochemotherapy in Patients With Relapsed Indolent B-cell Lymphoma
|
Matasar, Matthew J. |
|
|
21 |
11 |
p. e886-e894 |
artikel |
14 |
Long-Term Outcome of Philadelphia Chromosome Positive Leukemia From Eastern Indian Subcontinent: An Experience in the Era of Tyrosine Kinase Inhibitor (TKI) Therapy
|
Dey, Samya |
|
|
21 |
11 |
p. e876-e885 |
artikel |
15 |
Management and Outcome of Coronavirus Disease 2019 (COVID-19) in Pediatric Cancer Patients: A Single Centre Experience from a Developing Country
|
Hammad, Mahmoud |
|
|
21 |
11 |
p. e853-e864 |
artikel |
16 |
Ninety-Minute Daratumumab Infusions for Relapsed and Refractory Multiple Myeloma: Two Years of Italian Single-Center Observational Study
|
Attardi, Enrico |
|
|
21 |
11 |
p. e850-e852 |
artikel |
17 |
Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy
|
Wilson, Nathaniel R. |
|
|
21 |
11 |
p. 734-740 |
artikel |
18 |
Panobinostat From Bench to Bedside: Rethinking the Treatment Paradigm for Multiple Myeloma
|
Berdeja, Jesus G. |
|
|
21 |
11 |
p. 752-765 |
artikel |
19 |
Primary Mediastinal B-Cell Lymphoma: A 2021 Update on Genetics, Diagnosis, and Novel Therapeutics
|
Ahmed, Zahoor |
|
|
21 |
11 |
p. e865-e875 |
artikel |
20 |
Real-World Dosing Patterns of Ruxolitinib in Patients With Polycythemia Vera Who Are Resistant to or Intolerant of Hydroxyurea
|
Altomare, Ivy |
|
|
21 |
11 |
p. e915-e921 |
artikel |
21 |
Risk of Non-Hodgkin's Lymphoma in HCV Patients in the United States Between 2013 and 2020: A Population-Based Study
|
Alkrekshi, Akram |
|
|
21 |
11 |
p. e832-e838 |
artikel |
22 |
SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
|
Schmiegelow, Kjeld |
|
|
21 |
11 |
p. 725-733 |
artikel |
23 |
Table of Contents
|
|
|
|
21 |
11 |
p. A7-A9 |
artikel |
24 |
The Role of Interim PET/CT on Survival in Diffuse Large B Cell Lymphoma
|
Uluköylü Mengüç, Meral |
|
|
21 |
11 |
p. e922-e927 |
artikel |